Stage FocusSeed, Series A, Series B+
GeographyUS, Japan
TypeVC
Last Activity2026
Industry Focus
Industries
Biotech
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Remiges Ventures is a US-Japan cross-border life sciences venture firm founded in 2014, led by Managing Partner Taro Inaba alongside a team split across Seattle and Tokyo. Remiges also runs RDiscovery, an in-house drug discovery incubation arm chaired by Hans Keirstead, which closed an additional fund round in 2026.
The portfolio is entirely biotech and pharma: Viage Therapeutics, Omeicos Therape...
Notable Investments
V
Viage TherapeuticsO
Omeicos TherapeuticsC
Cyrano TherapeuticsG
GlycomineI
ImmunisK
KisoJi BiotechnologyE
ENB TherapeuticsR
Restore VisionSimilar Funds
3B
3E Bioventures Capital
China
Pure DeepTechBiotechMedtechSeedSeries A
AL
Advent Life Sciences
London, United Kingdom
Pure DeepTechBiotechMedtechSeedSeries A
AV
Alix Ventures
San Francisco, United States
Pure DeepTechBiotechSynthetic BiologyMedtechPre-SeedSeed
AH
Apollo Health Ventures
Berlin, Germany
Pure DeepTechBiotechSeedSeries A
Bold Capital Partners
Santa Monica, United States
Pure DeepTechBiotechAIMedtechSeedSeries A
DV
Digitalis Ventures
New York, United States
Pure DeepTechBiotechPre-SeedSeed